The analysis of clinical, functional and hemodynamic characteristics of PAH patients revealed that patients carriers of a BMPR2 or an ACVRL1 mutation are younger at diagnosis than patients with idiopathic PAH. Here, ACVRL1 is linked to pulmonary arterial hypertension.